EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers

Li Zeng, Yuwei Qian, Xiaoyan Cui, Jingying Zhao, Zhijun Ning, Jinglong Cha, Kun Wang, Changrong Ge, Junjing Jia, Tengfei Dou, Hongyan Chen, Lixian Liu und 2 weitere

Frontiers in Microbiology · 17.09.2025 · 16

DOI: 10.3389/fmicb.2025.1675065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 17.09.2025. Verfasst von Li Zeng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Animal Husbandry and Veterinary Medicine, Yunnan Vocational and Technical College of Agriculture, Kunming, Yunnan, China. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota modulates host immunity through a wide array of metabolic products that function as signaling molecules, thereby linking microbial activity with both mucosal and systemic immune responses. Notably, short-chain fatty acids, secondary bile acids, tryptophan-derived indoles, polyamines, and lipid derivatives play pivotal roles in regulating innate and adaptive immune functions via G protein-coupled receptors, nuclear receptors, and epigenetic pathways. These metabolites modulate immune cell differentiation, epithelial barrier integrity, and the resolution of inflammation in a dose- and site-specific manner. Recent advancements in spatial metabolomics, synthetic biology, and nanomedicine have facilitated the spatiotemporal delivery of these immunomodulatory compounds, revealing novel therapeutic avenues for the treatment of inflammatory and autoimmune disorders. This review summarizes the biosynthesis and immunoregulatory functions of key microbial metabolites, highlights the compartmentalized and systemic mechanisms of action, and discusses emerging therapeutic approaches, including postbiotics, engineered probiotics, and receptor-targeting drugs. We also explore the challenges in achieving personalized microbiome-immune modulation and propose future directions integrating multiomics and AI-driven predictive modeling. Understanding the metabolite-immune axis paves the way for novel interventions targeting host-microbe symbiosis.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotahost-microbiome interactionsimmune modulationmetabolitestherapeutic modulation

Autor:innen und Institutionen

  • Faculty of Animal Husbandry and Veterinary Medicine, Yunnan Vocational and Technical College of Agriculture, Kunming, Yunnan, China.
  • The Chenggong Department, Kunming Medical University Affiliated Stomatological Hospital, Kunming, Yunnan, China.
  • Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, Yunnan, China.
  • Institute of Science and Technology, Chuxiong Normal University, Chuxiong City, Yunnan, China.

Zitieren

APA

Zeng, L., Qian, Y., Cui, X., Zhao, J., Ning, Z., Cha, J., Wang, K., Ge, C., Jia, J., Dou, T., Chen, H., Liu, L., Bao, Z., & Jian, Z. (2025). Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1675065

Vancouver

Zeng L, Qian Y, Cui X, Zhao J, Ning Z, Cha J, et al. Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1675065

BibTeX
@article{Zeng2025,
  author = {Zeng, Li and Qian, Yuwei and Cui, Xiaoyan and Zhao, Jingying and Ning, Zhijun and Cha, Jinglong and Wang, Kun and Ge, Changrong and Jia, Junjing and Dou, Tengfei and Chen, Hongyan and Liu, Lixian and Bao, Zhipeng and Jian, Zonghui},
  title = {Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1675065}
}
Kostenlos starten →